To build a sustainable, impactful benefits strategy, HR leaders must ensure it aligns with both employee needs and business objectives. But this already complex task becomes more challenging when ...
How are benefit leaders handling persistent stressors in the workplace today, and is there room for improvement? According to exclusive research from Arizent, parent company of Employee Benefit News, ...
The decisions research funders make in allocating funds can have enormous consequences, directly impacting how scientific research advances knowledge, drives innovation, and solves pressing societal ...
This is part two in a two-part series on the current state of employee well-being. Read part one here. According to EBN's 2025 Workplace Well-being Survey, benefit leaders are prioritizing holistic ...
NEW YORK, June 10, 2025 – As U.S. employers grapple with heightened economic uncertainty and greater financial pressures on budgets, steering the right course on benefit strategy is more challenging ...
Inherited myopathies (IM) constitute a heterogeneous group of genetically based conditions that, regardless of the specific ...
With engagement on the downswing even as the end of 2024’s first half nears, nontraditional employee benefits emerged as an area of opportunity for employers, HR Dive’s 2024 Identity of HR survey ...
A benefit is a valued or desired outcome, or an advantage. In research, benefits generally fall into two categories: benefits to the individual participants in the research and benefits to science or ...
Jeff Bartel is chairman and managing director of Hamptons Group, a private investment and strategic advisory firm headquartered in Miami. For businesses interested in growth, especially in times of ...
Eligibility for Social Security retirement benefits starts at age 62. But for prospective beneficiaries who can wait, the biggest benefit becomes available at age 70. For many retirees, that poses a ...
An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardial infarction (NSTEMI) in older adults did not affect the combined risk of cardiovascular death or MI, although ...